合成香豆素-4-酮-噁二唑取代类似物作为有效的 -葡萄糖醛酸苷酶抑制剂。
Synthesis of Chromen-4-One-Oxadiazole Substituted Analogs as Potent -Glucuronidase Inhibitors.
机构信息
Department of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Department of Chemistry, Hazara University, Mansehra 21300, Khyber Pakhtunkhwa, Pakistan.
出版信息
Molecules. 2019 Apr 18;24(8):1528. doi: 10.3390/molecules24081528.
Abstract
Chromen-4-one substituted oxadiazole analogs - have been synthesized, characterized and evaluated for -glucuronidase inhibition. All analogs exhibited a variable degree of -glucuronidase inhibitory activity with IC values ranging in between 0.8 ± 0.1-42.3 ± 0.8 μM when compared with the standard d-saccharic acid 1,4 lactone (IC = 48.1 ± 1.2 μM). Structure activity relationship has been established for all compounds. Molecular docking studies were performed to predict the binding interaction of the compounds with the active site of enzyme.
摘要
已合成、表征并评价了色满-4-酮取代的噁二唑类似物的 -葡萄糖醛酸苷酶抑制活性。与标准的 D-葡萄糖二酸 1,4-内酯（IC = 48.1 ± 1.2 μM）相比，所有类似物均表现出不同程度的 -葡萄糖醛酸苷酶抑制活性，IC 值范围在 0.8 ± 0.1-42.3 ± 0.8 μM 之间。对所有化合物都建立了构效关系。进行了分子对接研究，以预测化合物与酶活性部位的结合相互作用。
相似文献
1
Synthesis of Chromen-4-One-Oxadiazole Substituted Analogs as Potent -Glucuronidase Inhibitors.
Molecules. 2019 Apr 18;24(8):1528. doi: 10.3390/molecules24081528.
2
Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent β-glucuronidase inhibitors and their molecular docking study.
Bioorg Med Chem. 2019 Jul 15;27(14):3145-3155. doi: 10.1016/j.bmc.2019.05.049. Epub 2019 Jun 4.
3
Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As β-glucuronidase inhibitors.
Bioorg Chem. 2017 Apr;71:86-96. doi: 10.1016/j.bioorg.2017.01.015. Epub 2017 Jan 26.
4
Synthesis of bis-indolylmethanes as new potential inhibitors of β-glucuronidase and their molecular docking studies.
Eur J Med Chem. 2018 Jan 1;143:1757-1767. doi: 10.1016/j.ejmech.2017.10.071. Epub 2017 Oct 26.
5
Synthesis and biological evaluation of novel N-arylidenequinoline-3-carbohydrazides as potent β-glucuronidase inhibitors.
Bioorg Med Chem. 2016 Aug 15;24(16):3696-704. doi: 10.1016/j.bmc.2016.06.008. Epub 2016 Jun 4.
6
Synthesis, β-glucuronidase inhibition and molecular docking studies of hybrid bisindole-thiosemicarbazides analogs.
Bioorg Chem. 2016 Oct;68:56-63. doi: 10.1016/j.bioorg.2016.07.008. Epub 2016 Jul 18.
7
Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies.
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1825-9. doi: 10.1016/j.bmcl.2014.02.015. Epub 2014 Feb 14.
8
Synthesis, Molecular Docking and β-Glucuronidase Inhibitory Potential of Indole Base Oxadiazole Derivatives.
Molecules. 2019 Mar 8;24(5):963. doi: 10.3390/molecules24050963.
9
Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies.
Bioorg Med Chem. 2015 Jul 1;23(13):3119-25. doi: 10.1016/j.bmc.2015.04.081. Epub 2015 May 6.
10
Synthesis of novel benzohydrazone-oxadiazole hybrids as β-glucuronidase inhibitors and molecular modeling studies.
Bioorg Med Chem. 2015 Dec 1;23(23):7394-404. doi: 10.1016/j.bmc.2015.10.037. Epub 2015 Oct 26.
引用本文的文献
1
Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
Eur J Med Chem. 2020 Feb 1;187:111921. doi: 10.1016/j.ejmech.2019.111921. Epub 2019 Dec 4.
本文引用的文献
1
Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs.
Bioorg Chem. 2018 Aug;78:201-209. doi: 10.1016/j.bioorg.2018.03.022. Epub 2018 Mar 20.
2
Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.
Bioorg Chem. 2018 Aug;78:58-67. doi: 10.1016/j.bioorg.2018.02.020. Epub 2018 Mar 7.
3
Synthesis, molecular docking study and thymidine phosphorylase inhibitory activity of 3-formylcoumarin derivatives.
Bioorg Chem. 2018 Aug;78:17-23. doi: 10.1016/j.bioorg.2018.02.028. Epub 2018 Mar 1.
4
Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Bioorg Chem. 2018 Apr;77:586-592. doi: 10.1016/j.bioorg.2018.01.033. Epub 2018 Feb 17.
5
Synthesis of bis-indolylmethanes as new potential inhibitors of β-glucuronidase and their molecular docking studies.
Eur J Med Chem. 2018 Jan 1;143:1757-1767. doi: 10.1016/j.ejmech.2017.10.071. Epub 2017 Oct 26.
6
Hybrid benzothiazole analogs as antiurease agent: Synthesis and molecular docking studies.
Bioorg Chem. 2016 Jun;66:80-7. doi: 10.1016/j.bioorg.2016.03.010. Epub 2016 Mar 24.
7
Synthesis of novel benzohydrazone-oxadiazole hybrids as β-glucuronidase inhibitors and molecular modeling studies.
Bioorg Med Chem. 2015 Dec 1;23(23):7394-404. doi: 10.1016/j.bmc.2015.10.037. Epub 2015 Oct 26.
8
Synthesis of novel flavone hydrazones: in-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies.
Eur J Med Chem. 2015 Nov 13;105:156-70. doi: 10.1016/j.ejmech.2015.10.017. Epub 2015 Oct 22.
9
Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
Bioorg Chem. 2015 Oct;62:15-21. doi: 10.1016/j.bioorg.2015.06.006. Epub 2015 Jun 29.
10
Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors.
Bioorg Chem. 2015 Aug;61:36-44. doi: 10.1016/j.bioorg.2015.05.010. Epub 2015 Jun 4.
Zotero 插件